(Q47285127)

English

A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

0 references

1 reference

based on heuristic

inferred from title

(RS)-sibutramine

1 reference

based on heuristic

inferred from title

6

object named as

David Black

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Lori L. Altshuler

3

object named as

Lori L Altshuler

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Gabriele S. Leverich

10

object named as

Gabriele S Leverich

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Susan L McElroy

1

object named as

Susan L McElroy

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

2

object named as

Mark A Frye

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

4

object named as

Trisha Suppes

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

12

object named as

Robert M Post

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

13

object named as

Paul E Keck

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

8

object named as

Ralph Kupka

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

9

object named as

Willem Nolen

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Kirk D Denicoff

11

object named as

Kirk D Denicoff

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Gerhard Hellemann

5

object named as

Gerhard Hellemann

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

author name string

Jim Mintz

7

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Bipolar Disorders

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

9

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

426-434

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Obesity as a correlate of outcome in patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Excess mortality in bipolar and unipolar disorder in Sweden

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

The efficacy and safety of sibutramine for weight loss: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Meta-analysis: pharmacologic treatment of obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Open-label adjunctive topiramate in the treatment of bipolar disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Hypomania with topiramate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Behavioural effects of the newer antiepileptic drugs: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Topiramate titration and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Effects of eating behavior on mood: a review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Exposure to appetitive food stimuli markedly activates the human brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

How can drug addiction help us understand obesity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Prevalence of obesity and weight change during treatment in patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00488.X

21 January 2018

Identifiers

10.1111/J.1399-5618.2007.00488.X

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17547588

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47285127&oldid=2150351861"